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Abstract
Introduction: Streptomyces spp. are aerobic, Gram-positive bacteria of the order Actinomycetales, known for their
ability to produce antimicrobial molecules such as streptomycin. Pneumonia due to Streptomyces is considered to
be rare and limited to immunocompromised patients. Streptomyces spp. are only rarely associated with invasive
systemic infections. To our knowledge, we report the first documented case of community-acquired Streptomyces
atratus bacteremic pneumonia in an immunocompetent patient.
Case presentation: We describe a case of Streptomyces atratus bacteremic pneumonia in an otherwise healthy,
77-year-old Spanish man. Streptomyces identified by 16S ribosomal RNA sequencing grew in multiple blood cultures
and bronchoalveolar lavage cultures. The infection resolved completely after treatment with imipenem and
amoxicillin/clavulanic acid for 2 months.
Conclusions: The majority of cases reported in the literature make reference to the difficulty of determining the
pathogenic role of Streptomyces spp. Usually considered a contaminant, the pathogenic role of Streptomyces spp. is
easier to confirm when the species is isolated from a catheter tip and, in the case of blood cultures, in more than
one sample with a high count of colonies. To our knowledge, we report the first documented case of Streptomyces
atratus bacteremic pneumonia in an immunocompetent patient. As the experience is limited, further studies are
needed to better understand the interpretation of the isolates of the genus Streptomyces; the predisposing factors
for infection; and the course, treatment, and evolution of these infections.
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Introduction
Streptomyces spp. are Gram-positive aerobic bacteria
that tend to form branches and filaments. The genus
Streptomyces belongs to the order Actinomycetales, along
with human pathogens of the genera Nocardia, Actinomy-
ces, Dermatophilus, and Mycobacterium [1]. The develop-
ment of molecular biological tools such as 16 ribosomal
RNA (rRNA) gene sequencing has led to modifications in
the methods of identification. The molecular identification
is rapid, and, in most cases, the results are unequivocal
[2]. Pneumonia due to Streptomyces is considered to be
rare and limited to immunocompromised patients. Strep-
tomyces spp. are only rarely associated with invasive sys-
temic infections [3]. To our knowledge, we report the first
documented case of Streptomyces atratus bacteremic
pneumonia in an immunocompetent patient.
Case presentation
A 77-year-old Spanish man was admitted to our hospital
in September 2012 after 10 days of marked general syn-
drome (asthenia, hyporexia, and 2-kg weight loss) accom-
panied by cough and mucopurulent sputum, dyspnea, and
low-grade fever. He had a 20 pack-year history of smok-
ing. He had no surgical background or other medical
background of interest.
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The clinical findings were as follows: body temperature
38.9 °C, blood pressure 170/80 mmHg, heart rate
110 beats/min, respiratory rate 30 breaths/min, and
oxygen saturation 72 % on room air. The patient’s
physical examination was normal except for pulmon-
ary auscultation. Diminished respiratory sounds and
crackles were found bilaterally at the bases of both
lungs. Laboratory tests revealed a 20,300 × 109/L
white blood cell count with 90 % neutrophils, 13.1 g/dl
hemoglobin, C-reactive protein 21.7 mg/L, procalcito-
nin (PCT) 2.84 ng/ml, and glucose 246 mg/dl. The pa-
tient’s platelet count, arterial blood clotting, and the rest
of the biochemical tests were within normal ranges. Arter-
ial blood gas analysis showed partial pressure of arterial
oxygen 32 mmHg, partial pressure of arterial carbon diox-
ide 76 mmHg, pH 7.37, and standard HCO3 35 mEq/L
(room air).
A chest x-ray revealed a right lung basal alveolar infil-
trate and a reticular interstitial pattern at the lung bases
(Fig. 1a). The results of urinary antigen for Pneumococ-
cus and Legionella, sputum cytology, mycobacterial cul-
ture, and serologic HIV tests were negative. Three blood
cultures were obtained upon admission from the same
site through a single venipuncture, and antibiotic treat-
ment with levofloxacin was initiated. Chest computed
tomography (CT) was performed 2 days after admission
because of persistence of fever and radiological worsen-
ing. Levofloxacin was replaced by a broad-spectrum
antibiotic (imipenem) on the third day of hospitalization.
The CT scan showed a right lower lobe alveolar consolida-
tion with minimal pleural effusion, severe bilateral diffuse
emphysema, and signs of chronic bronchitis (Fig. 1b). A
bronchoscopy with bronchoalveolar lavage (BAL) was per-
formed. The quantitative cultures of BAL specimens
yielded a Gram-positive aerobic branched, nonfragmented
bacillus at a concentration of 4 × 106 colony-forming units
per milliliter identified as S. atratus. No other pathogen
was isolated. The microbiology department confirmed S.
atratus growth in two blood cultures on the basis of 16S
rRNA gene sequencing. The isolate was sensitive to
amoxicillin-clavulanic acid, erythromycin, cefotaxime,
imipenem, gentamicin, tobramycin, ciprofloxacin, co-
trimoxazole, clarithromycin, and linezolid.
A control chest x-ray obtained 3 weeks later showed
radiological improvement (Fig. 2a). The patient was
treated with intravenous imipenem (2 g/day for 14 days)
and changed to oral amoxicillin-clavulanic acid (1000/
62.5 mg twice daily for 21 days). After 2 weeks of treat-
ment, the patient’s blood cultures were negative and his
PCT level was 0.10 ng/ml. On the basis of his clinical
and radiological improvement, the patient was dis-
charged. A control CT scan of the chest obtained at the
3-month follow-up visit showed almost complete reso-
lution of the right lower lobe consolidation (Fig. 2b).
The patient remained well at the 4-month and 6-month
follow-up visits.
Discussion
Streptomyces spp. comprise Gram-positive, extensively
branched, filamentous bacteria that form aerial hyphae
with chains of spores [1]. The streptomycetes are classi-
fied as a separate genus within the aerobic actinomycetes
and are most well known for the many antimicrobial
substances isolated from the approximately 600 different
species [1]. With the exception of specimens from acti-
nomycotic mycetoma, the isolation of Streptomyces from
clinical specimens is frequently considered laboratory
contamination [1]. Rare cases of clinical disease have
been published; however, in almost all of these cases,
there was an associated immunosuppression condition,
and Streptomyces was not the only potential pathogen
isolated. Our patient was immunocompetent, and Strep-
tomyces atratus was the only isolated pathogen in two
blood cultures and in the BAL culture.
Fig. 1 a Posteroanterior chest x-ray of the right lower lobe with alveolar infiltrate and a reticular interstitial pattern at the lung bases. b Chest
computed tomographic scan showing right lower lobe alveolar consolidation with minimal pleural effusion, severe bilateral diffuse emphysema,
and signs of chronic bronchitis.
Ariza-Prota et al. Journal of Medical Case Reports  (2015) 9:262 Page 2 of 4
Clinical situations such as host immune status, loca-
tion and chronicity of infection, and response to treat-
ment will likely dictate the intervention approach [3].
Invasive Streptomyces infections most often occur in im-
munocompromised patients with human HIV infection
or malignancy and in those treated with immunosup-
pressive agents such as corticosteroids and cancer
chemotherapy [4]. The selection of antibiotic for the
treatment of individual cases should be based on the in
vitro antibiotic susceptibility of the isolate [5]. Our pa-
tient was empirically first treated with levofloxacin for 2
days, but because the patient’s fever persisted his therapy
was modified to a broad-spectrum antibiotic (imipenem).
The blood cultures and the BAL culture confirmed Strep-
tomyces atratus species with antibiotic susceptibility to
amoxicillin-clavulanic acid, cefotaxime, imipenem, gen-
tamicin, tobramycin, ciprofloxacin, co-trimoxazole, clar-
ithromycin, and linezolid and without any resistance to
other antibiotics. Our patient was treated for the first 3
days with levofloxacin, but his treatment was modified
to imipenem because of persistent fever. He responded
well to treatment with imipenem and afterward to oral
amoxicillin-clavulanic acid.
We used PubMed (http://www.ncbi.nlm.nih.gov/
PubMed/) to search for literature on Streptomyces spp.
bacteremic pneumonia with the following index term:
“Streptomyces spp. bacteremic pneumonia.” A total of
only three clinical cases were found in the search. Only
one of these involved an immunocompetent patient,
and the case was due to Streptomyces lanatus species;
the other two cases were in immunocompromised pa-
tients. In contrast, our patient was immunocompetent,
and the use of inhaled corticosteroids in moderate doses
because of his COPD should not be considered as im-
munosuppressive, this makes our case even rarer and in-
teresting due to its almost zero frequency. This makes our
case even rarer and more interesting owing to its nearly
nonexistent occurrence. We also searched the literature
for reported cases of Streptomyces spp. nonbacteremic
pneumonia and found only seven cases. In most of these
cases, AIDS, advanced malignancies, or other serious dis-
eases that required treatment with immunosuppressives
were present. Other reported cases of invasive Streptomy-
ces infections include endocarditis of the prosthetic
valve, catheter-related bacteremia in a patient receiving
holistic infusions, bacteremia with thrombosis, pneu-
monia, pericarditis, peritonitis, arthritis, cervical lymph-
adenitis, brain abscess, and intraspinal mycetoma [6, 7]. In
all the reported cases of bacteremia due to Streptomyces,
the source was a catheter, prosthetic valve, intravenous in-
fusion, or primary lesion in internal organs such as the
lung.
A study of in vitro susceptibility of ten Streptomyces
strains revealed rifampin, erythromycin, tobramycin,
fusidic acid, and streptomycin sulfate as the most power-
ful antibiotics, whereas trimethoprim-sulfamethoxazole
(TMP-SMX) seemed ineffective [8]. The most potent
drugs were minocycline, imipenem, erythromycin, doxy-
cycline, and aminoglycosides, whereas a significant per-
centage of resistance to TMP-SMX, ampicillin, and
ciprofloxacin was noted [9]. This suggests that, in con-
trast to nocardiosis, TMP-SMX is not the drug of choice
for Streptomyces. The fact that Streptomyces spp. are
slow-growing bacteria renders prolongation of antibac-
terial treatment necessary [10]. In our patient, the S.
atratus isolate was not resistant to any of the tested
antibiotics.
In another investigation of BAL specimens from 247
immunocompromised patients, among others, 1 strain
of N. asteroides and 2 strains of Streptomyces spp. were
isolated [11]. An immunosuppressive condition was al-
ways associated in all the reported cases where Strepto-
myces spp. grew in BAL culture. Our patient was
immunocompetent.
Fig. 2 a Posteroanterior chest x-ray showing almost complete resolution of the right lower lobe alveolar infiltrate. b Chest computed tomographic
scan showing almost complete resolution of the right lower lobe consolidation.
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Conclusion
The majority of cases reported in the literature make
reference to the difficulty of determining the pathogenic
role of Streptomyces spp. because it is usually considered
as a contaminant. It is easier to confirm its pathogenic
condition when it is isolated from a catheter tip and, in
the case of blood cultures, in more than one sample with
a high count of colonies. To the best of our knowledge,
we report the first documented case of community-
acquired Streptomyces atratus bacteremic pneumonia in
an immunocompetent patient. As the experience is lim-
ited, further studies are needed to better understand the
interpretation of the isolates of the genus Streptomyces;
the predisposing factors for infection; and the course,
treatment, and evolution of these infections.
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